Psychiatric profile of three-month retention in cocaine- dependent patients treated in a therapeutic community

Journal of Studies on Alcohol and Drugs

Volumn 74, Issue 3, 2013, Pages 452-459

  Vergara Moragues, Esperanza ^a,b,c   González Saiz, Francisco ^d   Lozano, Oscar M ^e   García, Antonio Verdejo ^b,f  

^a UNIVERSIDAD INTERNACIONAL DE LA RIOJA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Agency of Social Services and Dependence of Andalusia   (Spain)

^d Mental Health Hospital   (Spain)

^e UNIVERSITY OF HUELVA   (Spain)

^f MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875350065     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2013.74.452     Document Type: Article

References (65)

1. Agosti, V., Nunes, E., Stewart, J. W., & Quitkin, F. M. (1991). Patient factors related to early attrition from an outpatient cocaine research clinic: A preliminary report. International Journal of the Addictions, 26, 327-334.
2. Alterman, A. I., Rutherford, M. J., Cacciola, J. S., McKay, J. R., & Woody, G. E. (1996). Response to methadone maintenance and counseling in antisocial patients with and without major depression. Journal of Nervous and Mental Disease, 184, 695-702.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Arenas, F., del Valle, M., López, R., Martín, J., & Tirado, P. (2003). Programa de Intervención. Comunidad Terapéutica en Andalucía. Sevilla: Consejería de Asuntos Sociales. Comisionado para las Drogodependencias. Junta de Andalucía.
5. Ariza, M. J., & Arenas, F. (Coords.). (2012). Protocolo de actuación conjunta Unidades de Salud Mental Comunitaria y Centros de Tratamiento Ambulatorio de Drogodependencias. Servicio Andaluz de Salud, Consejería de Salud. Junta de Andalucía, Seville, Spain.
6. Bleiberg, J. L., Devlin, P., Croan, J., & Briscoe, R. (1994). Relationship between treatment length and outcome in a therapeutic community. International Journal of the Addictions, 29, 729-740.
7. Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34, 791-806.
8. Bunt, G. C., Muehlbach, B., & Moed, C. O. (2008). The therapeutic community: An international perspective. Substance Abuse, 29, 81-87.
9. Carroll, K. M., & Rounsaville, B. J. (1993). History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry, 34, 75-82.
10. Condelli, W. S. (1994). Domains of variables for understanding and improving retention in therapeutic communities. International Journal of the Addictions, 29, 593-607.
11. Condelli, W. S., & De Leon, G. (1993). Fixed and dynamic predictors of client retention in therapeutic communities. Journal of Substance Abuse Treatment, 10, 11-16.
12. Condelli, W. S., & Dunteman, G. H. (1993). Issues to consider when predicting retention in therapeutic communities. Journal of Psychoactive Drugs, 25, 239-244.
13. Condelli, W. S., & Hubbard, R. L. (1994). Relationship between time spent in treatment and client outcomes from therapeutic communities. Journal of Substance Abuse Treatment, 11, 25-33.
14. Conners, C. K., Erhardt, D., & Sparrow, E. (1999). Conners' Adult ADHD Rating Scales. North Tonawanda, NY: Multi-Health Systems.
15. Darke, S., Campbell, G., & Popple, G. (2012). Retention, early dropout and treatment completion among therapeutic community admissions. Drug and Alcohol Review, 31, 64-71.
16. Daughters, S. B., Lejuez, C. W., Bornovalova, M. A., Kahler, C. W., Strong, D. R., & Brown, R. A. (2005). Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. Journal of Abnormal Psychology, 114, 729-734.
17. De Leon, G. (1986). The therapeutic community for substance abuse: Perspective and approach. In G. De Leon and J. T. Ziegenfuss (Eds.), Therapeutic communities for addictions. Springfield, IL: Charles C. Thomas.
18. De Leon, G. (1991). Retention in drug-free therapeutic communities. In R. W. Pickens, C. G. Leukefeld, and C. R. Schuster (Eds.), Improving drug abuse treatment (NIDA Research Monograph Series 106). Rockville, MD: U.S. Department of Health and Human Services.
19. De Leon, G., Sacks, S., Staines, G., & McKendrick, K. (2000). Modified therapeutic community for homeless mentally ill chemical abusers: Treatment outcomes. American Journal of Drug and Alcohol Abuse, 26, 461-480.
20. De Leon, G., & Schwartz, S. (1984). Therapeutic communities: What are the retention rates? American Journal of Drug and Alcohol Abuse, 10, 267-284.
21. Dekel, R., Benbenishty, R., & Amram, Y. (2004). Therapeutic communities for drug addicts: Prediction of long-term outcomes. Addictive Behaviors, 29, 1833-1837.
22. Fernández-Hermida, J. R., Secades-Villa, R., Fernández-Ludeña, J. J., & Marina-González, P. A. (2002). Effectiveness of a therapeutic community treatment in Spain: A long-term follow-up study. European Addiction Research, 8, 22-29.
23. Garfield, S. L. (1994). Research on client variables in psychotherapy. In A. E. Bergin and S. L. Garfield (Eds.), Handbook of psychotherapy and behavior change. New York, NY: John Wiley & Sons.
24. Gerstein, D. (1992). The effectiveness of drug treatment. In C. P. O'Brien and J. H. Jaffe (Eds.), Addictive states. New York, NY: Raven Press.
25. Gilchrist, G., Langohr, K., Fonseca, F., Muga, R., & Torrens, M. (2012). Factors associated with discharge against medical advice from and alcohol and drug inpatient detoxification unit in Barcelona between 1993 and 2006. Heroin Addiction & Related Clinical Problems, 14, 35-44.
26. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607-614.
27. Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (1999). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57, 89-98.
28. Greenfield, L., Burgdorf, K., Chen, X., Porowski, A., Roberts, T., & Herrell, J. (2004). Effectiveness of long-term residential substance abuse treatment for women: Findings from three national studies. American Journal of Drug and Alcohol Abuse, 30, 537-550.
29. Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. American Journal of Psychiatry, 163, 689-696.
30. Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11, 261-278.
31. Joe, G. W., Simpson, D. D., & Broome, K. M. (1998). Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction, 93, 1177-1190.
32. Johann, M., Bobbe, G., Putzhammer, A., & Wodarz, N. (2003). Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). Alcoholism: Clinical and Experimental Research, 27, 1527-1534.
33. Kaminer, Y., Tarter, R. E., Bukstein, O. G., & Kabene, M. (1992). Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1046-1049.
34. King, V. L., Brooner, R. K., Kidorf, M. S., Stoller, K. B., & Mirsky, A. F. (1999). Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease, 187, 487-495.
35. Kruedelbach, N., Walker, H. I., Chapman, H. A., Haro, G., Mateu, C., & Leal, C. (2006). Comorbidity on disorders with loss of impulse-control: Pathological gambling, addictions and personality disorders. Actas Españolas de Psiquiatría, 34, 76-82.
36. Lejuez, C. W., Zvolensky, M. J., Daughters, S. B., Bornovalova, M. A., Paulson, A., Tull, M. T., Otto, M. W. (2008). Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behaviour Research Therapy, 46, 811-818.
37. Levin, F. R., Evans, S. M., & Kleber, H. D. (1998). Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence, 52, 15-25.
38. Levin, F. R., Evans, S. M., Vosburg, S. K., Horton, T., Brooks, D., & Ng, J. (2004). Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors, 29, 1875-1882.
39. Lewis, B. J., & Ross, R. (1994). Retention in therapeutic communities: Challenges for the nineties. In F. M. Tims., G. De Leon, & N. Jainchill (Eds.), Therapeutic community: Advances in research and application. NIDA Research Monograph 144.
40. Llorente del Pozo, J. M., & Fernández Gómez, C. (1999). Comunidades terapéuticas. Situación actual y perspectivas de futuro. Adicciones, 11, 329-336.
41. Maglione, M., Chao, B., & Anglin, D. (2000). Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data Systems (CADDS), 1994-1997. Addiction Research & Theory, 8, 65-79.
42. Malivert, M., Fatséas, M., Denis, C., Langlois, E., & Auriacombe, M. (2012). Effectiveness of therapeutic communities: A systematic review. European Addiction Research, 18, 1-11.
43. Marsden, J., Eastwood, B., Bradbury, C., Dale-Perera, A., Farrell, M., Hammond, P., Wright, C. (2009). Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, intreatment cohort study. The Lancet, 374, 1262-1270.
44. McCusker, J., Vickers-Lahti, M., Stoddard, A., Hindin, R., Bigelow, C., Zorn, M., Lewis, B. (1995). The effectiveness of alternative planned durations of residential drug abuse treatment. American Journal of Public Health, 85, 1426-1429.
45. Messina, N., Wish, E., & Nemes, S. (2000). Predictors of treatment outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse, 26, 207-227.
46. Morgello, S., Holzer, C. E., 3rd., Ryan, E., Young, C., Naseer, M., Castellon, S. A., Frol, A. B., Singer, E. J. (2006). Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: Experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research, 15, 131-138.
47. Mulder, R. T., Frampton, C. M., Peka, H., Hampton, G., & Marsters, T. (2009). Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review, 28, 366-371.
48. Nielsen, A. L., & Scarpitti, F. R. (2002). Predicting retention in a therapeutic community for incarcerated substance abusers. Journal of Offender Rehabilitation, 34, 47-65.
49. Nielsen, D. A., Ho, A., Bahl, A., Varma, P., Kellogg, S., Borg, L., & Kreek, M. J. (2012). Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug and Alcohol Dependence, 124, 113-120.
50. Sacks, S., Chaple, M., Sacks, J. Y., McKendrick, K., & Cleland, C. M. (2012). Randomized trial of a reentry modified therapeutic community for offenders with co-occurring disorders: Crime outcomes. Journal of Substance Abuse Treatment, 42, 247-259.
51. Sacks, S., McKendrick, K., Sacks, J. Y., & Cleland, C. M. (2010). Modified therapeutic community for co-occurring disorders: Single investigator meta analysis. Substance Abuse, 31, 146-161.
52. Samuel, D. B., LaPaglia, D. M., Maccarelli, L. M., Moore, B. A., & Ball, S. A. (2011). Personality disorders and retention in a therapeutic community for substance dependence. American Journal on Addictions, 20, 555-562.
53. Secades Villa, R., & Fernández Hermida, J. R. (2000). Cómo mejorar las tasas de retención en los tratamientos de drogodependenicas. Adicciones, 12, 353-363.
54. Simpson, D. D. (1981). Treatment for drug abuse: Follow-up outcomes and length of time spent. Archives of General Psychiatry, 38, 875-880.
55. Simpson, D. D., Savage, L. J., & Lloyd, M. R. (1979). Follow-up evaluation of treatment of drug abuse during 1969 to 1972. Archives of General Psychiatry, 36, 772-780.
56. Stark, M. J. (1992). Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review, 12, 93-116.
57. Stowell, R. J. A. (1991). Adolescent substance abuse: Dual diagnosis issues. Psychiatric Annals, 21, 98-104.
58. Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., & Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161, 1231-1237.
59. Tull, M. T., & Gratz, K. L. (2012). The impact of borderline personality disorder on residential substance abuse treatment dropout among men. Drug and Alcohol Dependence, 121, 97-102.
60. Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008). Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews, 32, 777-810.
61. Vergara-Moragues, E., González-Saiz, F., Lozano, O. M., Betanzos Espinosa, P., Fernández Calderón, F., Bilbao-Acebos, I., Verdejo García, A. (2012). Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders. Psychiatry Research, 200, 734-741.
62. Vergara-Moragues, E., González-Saiz, F., Lozano Rojas, O., Bilbao Acedos, I., Fernández Calderón, F., Betanzos Espinosa, P., Pérez García, M. (2011). Diagnosing adult attention deficit/hyperactivity disorder in patients with cocaine dependence: discriminant validity of Barkley executive dysfunction symptoms. European Addiction Research, 17, 279-284.
63. Williams, M. T., & Roberts, C. S. (1991). Predicting length of stay in longterm treatment for chemically dependent females. International Journal of the Addictions, 26, 605-613.
64. Wise, B. K., Cuffe, S. P., & Fischer, T. (2001). Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment, 21, 161-165.
65. Zanarini, M. C., Frankenbur, F. R., Weingeroff, J. L., Reich, D. B., Fitzmaurice, G. M., & Weiss, R. D. (2011). The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: A 10-year follow-up study. Addiction, 106, 342-348.